Finnrick - Ensuring Safe and Transparent Supply Chain
Paramount Peptides

Paramount Peptides
Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP antagonist) from Paramount Peptides between 14 Jan 2025 and 20 Mar 2025. Tests score average over 4, no score below 3, and at least 6 tests warrant a confident Finnrick Rating of D (Poor).

Finnrick Rating™
D
POOR
Paramount Peptides
Tirzepatide
Tested 6 Samples
Last test 20 Mar 2025

Take Action

Mail in a Sample

We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.

Tirzepatide is also available from top-rated vendors:

All Tirzepatide tests from Paramount Peptides

Samples are tested in commercial labs

Tests Count

6

Scores

AVG6.2MIN3.6MAX8.1

Last

20 Mar 2025

First

14 Jan 2025
Quantity
Test Date
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
20 Mar 20257.410mg11.700mg+17.0%99.97%TIR10n01162025Blue Label / Clear CapLab BFinnrick
28 Feb 20257.710mg11.197mg+12.0%99.76%TIR10n01162025Blue Label / Clear CapLab CFinnrick
28 Feb 20258.110mg11.144mg+11.4%99.94%TIR10n01162025Blue Label / Clear CapLab CFinnrick
27 Feb 20256.010mg11.710mg+17.1%99.32%TIR10n01162025Blue Label / Clear CapLab AFinnrick
23 Jan 20253.610mg11.680mg+16.8%99.08%(no batch ID)(no data)Lab BFinnrick
14 Jan 20254.510mg10.950mg+9.5%98.91%(no batch ID)(no data)Lab AFinnrick